BlackRock’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,791,801
| Closed | -$285M | – | 5908 |
|
|
2022
Q2 | $285M | Buy |
3,791,801
+99,587
| +3% | +$7.49M | 0.01% | 1260 |
|
|
2022
Q1 | $99.1M | Sell |
3,692,214
-91,111
| -2% | -$2.45M | ﹤0.01% | 2123 |
|
|
2021
Q4 | $180M | Buy |
3,783,325
+32,589
| +0.9% | +$1.55M | ﹤0.01% | 1804 |
|
|
2021
Q3 | $249M | Sell |
3,750,736
-104,467
| -3% | -$6.94M | 0.01% | 1539 |
|
|
2021
Q2 | $301M | Buy |
3,855,203
+677,558
| +21% | +$52.9M | 0.01% | 1466 |
|
|
2021
Q1 | $301M | Buy |
3,177,645
+20,258
| +0.6% | +$1.92M | 0.01% | 1408 |
|
|
2020
Q4 | $385M | Buy |
3,157,387
+454,506
| +17% | +$55.4M | 0.01% | 1085 |
|
|
2020
Q3 | $236M | Buy |
2,702,881
+411,851
| +18% | +$36M | 0.01% | 1253 |
|
|
2020
Q2 | $148M | Buy |
2,291,030
+180,161
| +9% | +$11.6M | 0.01% | 1568 |
|
|
2020
Q1 | $94.3M | Sell |
2,110,869
-19,962
| -0.9% | -$891K | ﹤0.01% | 1671 |
|
|
2019
Q4 | $133M | Buy |
2,130,831
+1,414,535
| +197% | +$88.1M | 0.01% | 1776 |
|
|
2019
Q3 | $26.9M | Buy |
716,296
+138,408
| +24% | +$5.2M | ﹤0.01% | 2626 |
|
|
2019
Q2 | $23.5M | Buy |
+577,888
| New | +$23.5M | ﹤0.01% | 2735 |
|